The modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen

Yundeok Kim, Soo Jeong Kim, Dohyu Hwang, Jieun Jang, Shin Young Hyun, Yu Ri Kim, Jin Seok Kim, Yoo Hong Min, June Won Cheong

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: The modified Glasgow Prognostic Score (mGPS) consisting of serum C-reactive protein and albumin levels, shows significant prognostic value in several types of tumors. We evaluated the prognostic significance of mGPS in 285 patients with diffuse large B cell lymphoma (DLBCL), retrospectively.

Materials and Methods: According to mGPS classification, 204 patients (71.5%) had an mGPS of 0, 57 (20%) had an mGPS of 1, and 24 (8.5%) had an mGPS of 2.

Results: Our study found that high mGPS were associated with poor prognostic factors including older age, extranodal involvement, advanced disease stage, unfavorable International Prognostic Index scores, and the presence of B symptoms. The complete response (CR) rate after 3 cycles of R-CHOP chemotherapy was higher in patients with mGPS of 0 (53.8%) compared to those with mGPS of 1 (33.3%) or 2 (25.0%) (p=0.001). Patients with mGPS of 0 had significantly better overall survival (OS) than those with mGPS=1 and those with mGPS=2 (p=0.036). Multivariate analyses revealed that the GPS score was a prognostic factor for the CR rate of 3 cycle R-CHOP therapy (p=0.044) as well as OS (p=0.037).

Conclusion: mGPS can be considered a potential prognostic factor that may predict early responses to R-CHOP therapy in DLBCL patients.

Original languageEnglish
Pages (from-to)1568-1575
Number of pages8
JournalYonsei medical journal
Volume55
Issue number6
DOIs
Publication statusPublished - 2014 Nov 1

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Survival
C-Reactive Protein
Blood Proteins
Albumins
Multivariate Analysis
VAP-cyclo protocol
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kim, Yundeok ; Kim, Soo Jeong ; Hwang, Dohyu ; Jang, Jieun ; Hyun, Shin Young ; Kim, Yu Ri ; Kim, Jin Seok ; Min, Yoo Hong ; Cheong, June Won. / The modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen. In: Yonsei medical journal. 2014 ; Vol. 55, No. 6. pp. 1568-1575.
@article{209b8ffed33a4ccca3e69628889bc3e2,
title = "The modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen",
abstract = "Purpose: The modified Glasgow Prognostic Score (mGPS) consisting of serum C-reactive protein and albumin levels, shows significant prognostic value in several types of tumors. We evaluated the prognostic significance of mGPS in 285 patients with diffuse large B cell lymphoma (DLBCL), retrospectively.Materials and Methods: According to mGPS classification, 204 patients (71.5{\%}) had an mGPS of 0, 57 (20{\%}) had an mGPS of 1, and 24 (8.5{\%}) had an mGPS of 2.Results: Our study found that high mGPS were associated with poor prognostic factors including older age, extranodal involvement, advanced disease stage, unfavorable International Prognostic Index scores, and the presence of B symptoms. The complete response (CR) rate after 3 cycles of R-CHOP chemotherapy was higher in patients with mGPS of 0 (53.8{\%}) compared to those with mGPS of 1 (33.3{\%}) or 2 (25.0{\%}) (p=0.001). Patients with mGPS of 0 had significantly better overall survival (OS) than those with mGPS=1 and those with mGPS=2 (p=0.036). Multivariate analyses revealed that the GPS score was a prognostic factor for the CR rate of 3 cycle R-CHOP therapy (p=0.044) as well as OS (p=0.037).Conclusion: mGPS can be considered a potential prognostic factor that may predict early responses to R-CHOP therapy in DLBCL patients.",
author = "Yundeok Kim and Kim, {Soo Jeong} and Dohyu Hwang and Jieun Jang and Hyun, {Shin Young} and Kim, {Yu Ri} and Kim, {Jin Seok} and Min, {Yoo Hong} and Cheong, {June Won}",
year = "2014",
month = "11",
day = "1",
doi = "10.3349/ymj.2014.55.6.1568",
language = "English",
volume = "55",
pages = "1568--1575",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "6",

}

The modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen. / Kim, Yundeok; Kim, Soo Jeong; Hwang, Dohyu; Jang, Jieun; Hyun, Shin Young; Kim, Yu Ri; Kim, Jin Seok; Min, Yoo Hong; Cheong, June Won.

In: Yonsei medical journal, Vol. 55, No. 6, 01.11.2014, p. 1568-1575.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen

AU - Kim, Yundeok

AU - Kim, Soo Jeong

AU - Hwang, Dohyu

AU - Jang, Jieun

AU - Hyun, Shin Young

AU - Kim, Yu Ri

AU - Kim, Jin Seok

AU - Min, Yoo Hong

AU - Cheong, June Won

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Purpose: The modified Glasgow Prognostic Score (mGPS) consisting of serum C-reactive protein and albumin levels, shows significant prognostic value in several types of tumors. We evaluated the prognostic significance of mGPS in 285 patients with diffuse large B cell lymphoma (DLBCL), retrospectively.Materials and Methods: According to mGPS classification, 204 patients (71.5%) had an mGPS of 0, 57 (20%) had an mGPS of 1, and 24 (8.5%) had an mGPS of 2.Results: Our study found that high mGPS were associated with poor prognostic factors including older age, extranodal involvement, advanced disease stage, unfavorable International Prognostic Index scores, and the presence of B symptoms. The complete response (CR) rate after 3 cycles of R-CHOP chemotherapy was higher in patients with mGPS of 0 (53.8%) compared to those with mGPS of 1 (33.3%) or 2 (25.0%) (p=0.001). Patients with mGPS of 0 had significantly better overall survival (OS) than those with mGPS=1 and those with mGPS=2 (p=0.036). Multivariate analyses revealed that the GPS score was a prognostic factor for the CR rate of 3 cycle R-CHOP therapy (p=0.044) as well as OS (p=0.037).Conclusion: mGPS can be considered a potential prognostic factor that may predict early responses to R-CHOP therapy in DLBCL patients.

AB - Purpose: The modified Glasgow Prognostic Score (mGPS) consisting of serum C-reactive protein and albumin levels, shows significant prognostic value in several types of tumors. We evaluated the prognostic significance of mGPS in 285 patients with diffuse large B cell lymphoma (DLBCL), retrospectively.Materials and Methods: According to mGPS classification, 204 patients (71.5%) had an mGPS of 0, 57 (20%) had an mGPS of 1, and 24 (8.5%) had an mGPS of 2.Results: Our study found that high mGPS were associated with poor prognostic factors including older age, extranodal involvement, advanced disease stage, unfavorable International Prognostic Index scores, and the presence of B symptoms. The complete response (CR) rate after 3 cycles of R-CHOP chemotherapy was higher in patients with mGPS of 0 (53.8%) compared to those with mGPS of 1 (33.3%) or 2 (25.0%) (p=0.001). Patients with mGPS of 0 had significantly better overall survival (OS) than those with mGPS=1 and those with mGPS=2 (p=0.036). Multivariate analyses revealed that the GPS score was a prognostic factor for the CR rate of 3 cycle R-CHOP therapy (p=0.044) as well as OS (p=0.037).Conclusion: mGPS can be considered a potential prognostic factor that may predict early responses to R-CHOP therapy in DLBCL patients.

UR - http://www.scopus.com/inward/record.url?scp=84908244567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908244567&partnerID=8YFLogxK

U2 - 10.3349/ymj.2014.55.6.1568

DO - 10.3349/ymj.2014.55.6.1568

M3 - Article

C2 - 25323893

AN - SCOPUS:84908244567

VL - 55

SP - 1568

EP - 1575

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 6

ER -